Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Open in API
Filings indexed 1,687 across all filing types
Latest filing 2023-06-29 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SVBI

www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
公告本公司交鏈透明質酸FLEXVISC Plus 加強型關節腔注射劑產品取得銷售許可證書
Regulatory Filings Classification · 95% confidence The document is a short announcement (869 characters) from a company named 科妍生物科技股份有限公司 about obtaining a sales permit for a medical product (FLEXVISC Plus). It includes details about the product, regulatory approval, and expected business impact. There is no financial data, no mention of financial results, no management discussion, no voting results, no board changes, no merger or acquisition activity, and no detailed report content. The document is a regulatory announcement about a product approval, which affects shareholder interests but is not a financial report or detailed filing. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-06-29 Chinese
功能性委員會成員
Board/Management Information Classification · 90% confidence The document is very short (236 characters) and contains a table listing company code, name, establishment date, and member names with expertise and operational information. There is no financial data, no report title, no regulatory form references, and no indication of a report or announcement. The content resembles a disclosure of board or committee members, which aligns with Board/Management Information filings. Given the brevity and content, it is not a full report but an announcement of management or board composition.
2023-06-29 Chinese
功能性委員會成員
Regulatory Filings Classification · 95% confidence The document is a brief tabular disclosure from a public information observation station, listing company code, name, establishment date, audit committee members, financial/accounting expertise, independent directors, total directors, and operational information. It is very short (386 characters) and contains no financial statements, no management discussion, no voting results, no legal proceedings, no capital changes, or any other detailed report content. It appears to be a regulatory disclosure about board composition and audit committee members, but not a full governance report or management report. Given the brevity and nature, it fits best as a Regulatory Filing (RNS) which is a fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-06-29 Chinese
111年度股利金額(股東會決議)
Notice of Dividend Amount Classification · 100% confidence The document text is a detailed announcement of dividend distribution information for a company, including dividend amounts, dates, and related notes. It does not contain a full financial report or comprehensive financial statements. The content focuses on dividend amounts and shareholder distribution details, which aligns with a Notice of Dividend Amount filing. The document length is short (1896 characters), and it is not an announcement of a report publication but the actual dividend distribution details. Therefore, the appropriate classification is Notice of Dividend Amount (DIV).
2023-06-28 Chinese
公告本公司民國111年度配息基準日
Notice of Dividend Amount Classification · 100% confidence The document is a short announcement from a company regarding the dividend distribution details for the fiscal year 111 (2022/2023). It includes information such as the dividend type (cash dividend), amount, ex-dividend date, record date, and payment date. The document does not contain financial statements or detailed financial analysis but rather provides specific dividend payment information. This matches the definition of a Notice of Dividend Amount (DIV). The document length is short and focused solely on dividend details, confirming it is not a full report or earnings release but a dividend announcement.
2023-06-28 Chinese
公告本公司董事會通過委任第二屆審計委員會委員
Board/Management Information Classification · 100% confidence The document is a public announcement from a listed company (1786 科妍) regarding changes in the composition of its Audit Committee members, including names, previous and new members, and reasons for the change (term expiration and reappointment). It does not contain financial data, audit results, or detailed reports but is an announcement of board/committee member changes. This fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming the classification.
2023-06-28 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.